Update Chronic Viral Hepatitis B and C

Terziroli Beretta-Piccoli, Benedetta; Schranz, Melanie; De Gottardi, Andrea; Cerny, Andreas (2015). Update Chronic Viral Hepatitis B and C. Praxis - schweizerische Rundschau für Medizin, 104(25), pp. 1393-1397. Huber 10.1024/1661-8157/a002207

Text Update chronische Hepatitis B und C .pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (289kB)

Chronic hepatitis B has a complex natural history. The age at infection, comorbidities, coinfections, and other, yet to be identified factors, determine the probability of developing a chronic infection. The HBV virus can never be completely eliminated and remains in the hepatocytes for life. However, to reach an inactive carrier status is a realistic goal of the therapy. For HBV treatment, pegylated interferon and direct antivirals are available. To screen persons at risk and to vaccinate all of the population are important prophylactic measures. Chronic hepatitis C infection leads, in 30% of cases, to liver cirrhosis. Treatment is recommended from fibrosis stage Metavir 2. New DAA allows short treatment, with a high response rate and very few adverse effects.

Interest & Impact

Downloads

2 since deposited on 30 Mar 2016
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item